Comparative Effectiveness and Safety of Angiotensin-Converting Enzyme Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs) in Older Adults with Type 2 Diabetes

04/01/2022
02/07/2024
EU PAS number:
EUPAS44899
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

ACEI v ARB_RWE protocol_30DEC2021

English (594.66 KB - PDF) View document
Study results
Study report
Other information